AAVnerGene
Pre-clinicalAt AAVnerGene, we specialize in advancing the frontiers of gene therapy through cutting-edge AAV technologies, services and products. Our comprehensive AAV
Founded
2020
Focus
Viral Technology
About
At AAVnerGene, we specialize in advancing the frontiers of gene therapy through cutting-edge AAV technologies, services and products. Our comprehensive AAV
Funding History
2Total raised: $20.5M
Series A$15MUndisclosedNov 15, 2022
Seed$5.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile